Acquired Immune Deficiency Syndrome Virus
Showing 9976 - 10000 of >10,000
Yellow Fever Vaccination Reaction Trial in Frederick (Yellow Fever Vaccine)
Active, not recruiting
- Yellow Fever Vaccination Reaction
- Yellow Fever Vaccine
-
Frederick, MarylandUnited States Army Medical Research Institute of Infectious Dise
May 17, 2022
Risk Factors in Early Multiple Sclerosis
Recruiting
- Multiple Sclerosis
- +4 more
- Brain MRI
-
Aurora, ColoradoUniversity of Colorado Anschutz Medical Campus
Aug 4, 2021
Exercise Training on Single Ventricle Function in Paediatric
Not yet recruiting
- Univentricular Heart
-
Dublin, IrelandChildren's Health Ireland
Dec 20, 2022
Recurrent Glioma, Recurrent Glioblastoma, Poly ADP Ribose Polymerase (PARP) Inhibitor Trial in Hong Kong (Talazoparib)
Recruiting
- Recurrent Glioma
- +4 more
-
Hong Kong, Hong KongDepartment of Clinical Oncology
Aug 19, 2021
Nasopharyngeal Carcinoma Trial in Worldwide (Spartalizumab, Investigator choice of chemo)
Completed
- Nasopharyngeal Carcinoma
- Spartalizumab
- Investigator choice of chemotherapy
-
Marietta, Georgia
- +17 more
Jan 17, 2022
Advanced Malignant Solid Tumor, C-KIT Tyrosine Kinase Protein Overexpression, Clinical Stage IV Cutaneous Melanoma AJCC v8 Trial
Recruiting
- Advanced Malignant Solid Neoplasm
- +8 more
- Imatinib Mesylate
- Ipilimumab
-
Houston, TexasM D Anderson Cancer Center
Aug 1, 2022
Allergic Conjunctivitis, Dry Eye, Dry Eye Disease Trial in Catanzaro (HPMC-HA eyedrops)
Completed
- Allergic Conjunctivitis
- +2 more
- HPMC-HA eyedrops
-
Catanzaro, CZ, ItalyAzienda Ospedaliera Policlinico Mater Domini - Università Magna
Apr 13, 2023
Acute Respiratory Distress Syndrome, SARS-CoV-2 Trial in United States (PLN-74809, Placebo)
Terminated
- Acute Respiratory Distress Syndrome
- SARS-CoV-2
- PLN-74809
- Placebo
-
Phoenix, Arizona
- +5 more
Oct 8, 2021
HIV Trial in Worldwide (PENNVAX-G DNA Vaccine, MVA-CMDR Vaccine, Placebo PENNVAX-G Vaccine)
Completed
- HIV Infections
- PENNVAX-G DNA Vaccine
- +3 more
-
Rockville, Maryland
- +3 more
Oct 28, 2021
SARS-CoV2 COVID-19 Trial in Randwick, Adelaide, Perth (COVIGEN C19 0.8 mg ID or Placebo ID, COVIGEN C19 2.0 mg IM or Placebo IM,
Active, not recruiting
- SARS-CoV2 COVID-19
- COVIGEN C19 0.8 mg ID or Placebo ID
- +3 more
-
Randwick, New South Wales, Australia
- +2 more
Nov 17, 2022
Liver Failure Trial in Ningbo (fecal microbiota transplantation)
Recruiting
- Liver Failure
- fecal microbiota transplantation
-
Ningbo, Zhejiang, ChinaNingbo Medical Center Lihuili Hospital,Affiliated Lihuili hospit
Dec 9, 2021
Alport Syndrome Trial in Worldwide (Placebo Oral Capsule, Bardoxolone Methyl)
Completed
- Alport Syndrome
- Placebo Oral Capsule
- Bardoxolone Methyl
-
Birmingham, Alabama
- +62 more
Mar 22, 2022
Kidney Transplant, Kidney Failure, Highly Sensitized Trial in Boston, New York, Philadelphia (Cyclophosphamide, CART-BCMA,
Not yet recruiting
- Kidney Transplant
- +2 more
- Cyclophosphamide
- +3 more
-
Boston, Massachusetts
- +2 more
Sep 20, 2023
Obstructive Sleep Apnea Syndrome Trial in Istanbul (Gradual Aerobic exercise training and Respiratory muscle training)
Recruiting
- Obstructive Sleep Apnea Syndrome
- Gradual Aerobic exercise training and Respiratory muscle training
-
Istanbul, TurkeyIstanbul University Istanbul Medical Faculty
Mar 29, 2022
Invasive Bladder Cancer Trial in Madrid (Atezolizumab, BCG)
Recruiting
- Invasive Bladder Cancer
-
Madrid, SpainHospital 12 de Octubre
Feb 8, 2022
Improve Intrapartum Sonography Skills.
Not yet recruiting
- Obstetric Labor
- (no location specified)
Jul 18, 2022
Pulmonary Embolism Trial in Vienna (Rehabilitation)
Recruiting
- Pulmonary Embolism
- Rehabilitation
-
Vienna, AustriaTherme Wien Med
May 6, 2022
Primary Immunodeficiency Trial in United States (Immune Globulin Intravenous, Prometic's Immune Globulin Intravenous 10%)
Completed
- Primary Immunodeficiency
- Immune Globulin Intravenous
- Prometic's Immune Globulin Intravenous 10%
-
Irvine, California
- +12 more
Nov 3, 2021
Tuberculosis Trial (zinc 50 mg + Epigallocatechin gallate)
Not yet recruiting
- Tuberculosis
- zinc 50 mg + Epigallocatechin gallate
- (no location specified)
Nov 1, 2021
Influenza Trial in India (Quadrivalent Inactivated Influenza Vaccine (2016-2017 NH formulation), No Preservative, Quadrivalent
Completed
- Influenza
- Quadrivalent Inactivated Influenza Vaccine (2016-2017 NH formulation), No Preservative
- +3 more
-
Vadodara, Gujarat, India
- +7 more
Mar 24, 2022
Tourette Syndrome Trial in Gainesville (DBS System, DBS System (RBS Setting))
Active, not recruiting
- Tourette Syndrome
- DBS System
- DBS System (RBS Setting)
-
Gainesville, FloridaUniversity of Florida
Dec 21, 2021
COVID-19 Infection, COVID-19 Vaccine Adverse Reaction Trial in Seoul (LEM-mR203, Placebo)
Not yet recruiting
- COVID-19 Infection
- COVID-19 Vaccine Adverse Reaction
- LEM-mR203
- Placebo
-
Seoul, Korea, Republic ofSeoul National University Hospital Clinical Trials Center
Sep 12, 2023
Bodily Distress Disorder Moderate, Fibromyalgia, Chronic Fatigue Syndrome Trial (Internet-delivered treatment: "One step at the
Withdrawn
- Bodily Distress Disorder Moderate
- +4 more
- Internet-delivered treatment: "One step at the time"
- (no location specified)
Oct 7, 2022
Small Cell Lung Cancer Trial in Worldwide (Trilaciclib, Placebo, Carboplatin)
Terminated
- Small Cell Lung Cancer
- Trilaciclib
- +4 more
-
Beverly Hills, California
- +44 more
Apr 8, 2022
Metastatic Castrate-resistant Prostate Cancer, mCRPC Trial in Dallas (Sipuleucel-T, Stereotactic Ablative Body Radiation)
Completed
- Metastatic Castrate-resistant Prostate Cancer
- mCRPC
- Sipuleucel-T
- Stereotactic Ablative Body Radiation
-
Dallas, TexasUniversity of Texas Southwestern Medical Center
Apr 11, 2022